Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cameco Corp. buy BiotechBee

Start price
€28.02
03.10.22 / 50%
Target price
€37.00
31.12.24
Performance (%)
-26.25%
End price
€20.67
21.12.22
Summary
This prediction ended on 21.12.22 with a price of €20.67. The prediction for Cameco Corp. disappointed with a performance of -26.25%. Dividends of €0.063 are taken into consideration when calculating the performance. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cameco Corp. -6.024% -6.024% 71.623%
iShares Core DAX® -0.992% -3.231% 11.661%
iShares Nasdaq 100 -0.225% -3.339% 36.491%
iShares Nikkei 225® -0.736% -7.859% 18.597%
iShares S&P 500 -0.509% -2.979% 26.341%

According to BiotechBee what are the pros and cons of Cameco Corp. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by BiotechBee for this prediction

In the thread Cameco Corp. diskutieren
Prediction Buy
Perf. (%) -26.25%
Target price 37.000
Change
Ends at 31.12.24

Buy mit Kursziel 37,0

In the thread Trading Cameco Corp.
Prediction Buy
Perf. (%) -26.25%
Target price 37.000
Change
Ends at 31.12.24

Buy beendet